Estimation of Benefit From Regular Versus Leakage-related Exchange of Voice Prosthesis in Patients Post Laryngectomy. (RvLPE)
Primary Purpose
Laryngectomy, Voice, Prosthesis Failure
Status
Unknown status
Phase
Not Applicable
Locations
Poland
Study Type
Interventional
Intervention
Provox prosthesis exchange
Sponsored by
About this trial
This is an interventional prevention trial for Laryngectomy focused on measuring voice prosthesis, laryngectomy, complications
Eligibility Criteria
Inclusion Criteria:
- patients post laryngectomy with primary insertion of voice prosthesis
Exclusion Criteria:
- patients post laryngopharyngectomy with digestive tract reconstruction with jejunum of free flap
Sites / Locations
- Department of Otorhinolaryngology, Head andNeck Surgery of Medical University of Warsaw
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Regular exchange
Leakage exchange
Arm Description
Patients will be appointed each 3 months for regular exchange of voice prosthesis.
Patients will have voice prosthesis exchange when leakage occurs.
Outcomes
Primary Outcome Measures
Comparison of complications rate.
In both arms of the study we will compare the incidence of following complications: periprosthetic leakage, granulation or atrophy of mucosa around the fistula, dislocation of prosthesis
Secondary Outcome Measures
Fistula colonization with Candida species.
We will compare microbiological results on subsequent prosthesis exchanges in both arms.
Prosthesis replacement scheme and patient satisfaction.
On each voice prosthesis exchange patients will be asked three questions, assessed with Visual Analog Scale, on their feedback on voice prosthesis use, procedure of prosthesis replacement and voice quality.
Full Information
NCT ID
NCT04268459
First Posted
February 10, 2020
Last Updated
February 10, 2020
Sponsor
Medical University of Warsaw
1. Study Identification
Unique Protocol Identification Number
NCT04268459
Brief Title
Estimation of Benefit From Regular Versus Leakage-related Exchange of Voice Prosthesis in Patients Post Laryngectomy.
Acronym
RvLPE
Official Title
Estimation of Benefit From Regular Versus Leakage-related Exchange of Voice Prosthesis in Patients Post Laryngectomy Considering Complications Rate, Fistula Colonization by Candida Species and Patients Satisfaction Feedback.
Study Type
Interventional
2. Study Status
Record Verification Date
February 2020
Overall Recruitment Status
Unknown status
Study Start Date
March 10, 2020 (Anticipated)
Primary Completion Date
March 10, 2021 (Anticipated)
Study Completion Date
March 31, 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of Warsaw
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The tracheoesophageal voice with voice prosthesis is currently the mainstay of voice rehabilitation post laryngectomy. The primary surgical technique of tracheoesophageal fistula formation with insertion of prosthesis and quick and easy process of voice rehabilitation are main encouraging factors. However, the usage of the prosthesis relates to a significant number of complications rated from 10 to 60%. The most common reported complication is transprosthetic leakage that determines the need of device exchange. However in some patients occur more serious complications eg. periprosthetic leakage, granulation or atrophy of mucosa around the fistula, dislocation of prosthesis, that may require anti-inflammatory treatment, temporary nasogastric tube feeding or surgical procedure. The standard protocol is voice prosthesis exchange due to transprosthetic leakage. Optionally the device could be replaced regularly to prevent both transprosthetic leakage and other complication occurrence.
In the study we plan to compare the benefits from regular (each three month) versus leakage-related exchange of voice prosthesis post laryngectomy including the rate of complications, fistula colonization by Candida species and patients feedback.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Laryngectomy, Voice, Prosthesis Failure
Keywords
voice prosthesis, laryngectomy, complications
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
randomized controlled trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
70 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Regular exchange
Arm Type
Active Comparator
Arm Description
Patients will be appointed each 3 months for regular exchange of voice prosthesis.
Arm Title
Leakage exchange
Arm Type
Active Comparator
Arm Description
Patients will have voice prosthesis exchange when leakage occurs.
Intervention Type
Device
Intervention Name(s)
Provox prosthesis exchange
Intervention Description
Each patient post laryngectomy will be randomly assigned to one arm of intervention. The voice prosthesis exchange in all patients will be performed in local anaesthesia. The microbiological samples with cotton swabs will be collected from tracheoesophageal fistula on prosthesis exchange. The clinical evaluation and patients satisfaction from prosthesis usage will be performed on each exchange.
Primary Outcome Measure Information:
Title
Comparison of complications rate.
Description
In both arms of the study we will compare the incidence of following complications: periprosthetic leakage, granulation or atrophy of mucosa around the fistula, dislocation of prosthesis
Time Frame
Control will be continued for 12 months post laryngectomy.
Secondary Outcome Measure Information:
Title
Fistula colonization with Candida species.
Description
We will compare microbiological results on subsequent prosthesis exchanges in both arms.
Time Frame
Control will be continued for 12 months post laryngectomy.
Title
Prosthesis replacement scheme and patient satisfaction.
Description
On each voice prosthesis exchange patients will be asked three questions, assessed with Visual Analog Scale, on their feedback on voice prosthesis use, procedure of prosthesis replacement and voice quality.
Time Frame
Control will be continued for 12 months post laryngectomy.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patients post laryngectomy with primary insertion of voice prosthesis
Exclusion Criteria:
patients post laryngopharyngectomy with digestive tract reconstruction with jejunum of free flap
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anna Rzepakowska, PhD
Phone
+48225992521
Email
arzepakowska@wum.edu.pl
First Name & Middle Initial & Last Name or Official Title & Degree
Daniel Majszyk, PhD
Phone
+48225992521
Email
daniel.majszyk@wum.edu.pl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anna Rzepakowska, PhD
Organizational Affiliation
Medical University of Warsaw
Official's Role
Study Chair
Facility Information:
Facility Name
Department of Otorhinolaryngology, Head andNeck Surgery of Medical University of Warsaw
City
Warsaw
ZIP/Postal Code
02-097
Country
Poland
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anna Rzepakowska, PhD
Phone
+48225992521
Email
arzepakowska@wum.edu.pl
First Name & Middle Initial & Last Name & Degree
Ewa Osuch-Wójcikiewicz, Professor
Phone
+48225992521
Email
eosuch@wum.edu.pl
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Time Frame
Date will become available from April 2022 until April 2023.
IPD Sharing Access Criteria
on request
Learn more about this trial
Estimation of Benefit From Regular Versus Leakage-related Exchange of Voice Prosthesis in Patients Post Laryngectomy.
We'll reach out to this number within 24 hrs